These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 27222470)

  • 1. Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis.
    Gengenbacher M; Nieuwenhuizen N; Vogelzang A; Liu H; Kaiser P; Schuerer S; Lazar D; Wagner I; Mollenkopf HJ; Kaufmann SH
    mBio; 2016 May; 7(3):. PubMed ID: 27222470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice.
    Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH
    mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-exposure vaccination with the vaccine candidate Bacillus Calmette-Guérin ΔureC::hly induces superior protection in a mouse model of subclinical tuberculosis.
    Gengenbacher M; Kaiser P; Schuerer S; Lazar D; Kaufmann SH
    Microbes Infect; 2016 May; 18(5):364-8. PubMed ID: 26994939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice.
    Rao M; Vogelzang A; Kaiser P; Schuerer S; Kaufmann SH; Gengenbacher M
    PLoS One; 2013; 8(11):e78966. PubMed ID: 24236077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleeping Beauty and the Story of the Bacille Calmette-Guérin Vaccine.
    Fletcher HA
    mBio; 2016 Aug; 7(4):. PubMed ID: 27578760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ΔureC::hly vaccine's superior protection against tuberculosis.
    Vogelzang A; Perdomo C; Zedler U; Kuhlmann S; Hurwitz R; Gengenbacher M; Kaufmann SH
    J Infect Dis; 2014 Dec; 210(12):1928-37. PubMed ID: 24943726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Recombinant BCG ΔureC::hly Vaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation.
    Saiga H; Nieuwenhuizen N; Gengenbacher M; Koehler AB; Schuerer S; Moura-Alves P; Wagner I; Mollenkopf HJ; Dorhoi A; Kaufmann SH
    J Infect Dis; 2015 Jun; 211(11):1831-41. PubMed ID: 25505299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
    Tchilian EZ; Desel C; Forbes EK; Bandermann S; Sander CR; Hill AV; McShane H; Kaufmann SH
    Infect Immun; 2009 Feb; 77(2):622-31. PubMed ID: 19064635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.
    Grode L; Seiler P; Baumann S; Hess J; Brinkmann V; Nasser Eddine A; Mann P; Goosmann C; Bandermann S; Smith D; Bancroft GJ; Reyrat JM; van Soolingen D; Raupach B; Kaufmann SH
    J Clin Invest; 2005 Sep; 115(9):2472-9. PubMed ID: 16110326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCG - old workhorse, new skills.
    Gengenbacher M; Nieuwenhuizen NE; Kaufmann S
    Curr Opin Immunol; 2017 Aug; 47():8-16. PubMed ID: 28719821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis.
    Festjens N; Bogaert P; Batni A; Houthuys E; Plets E; Vanderschaeghe D; Laukens B; Asselbergh B; Parthoens E; De Rycke R; Willart MA; Jacques P; Elewaut D; Brouckaert P; Lambrecht BN; Huygen K; Callewaert N
    EMBO Mol Med; 2011 Apr; 3(4):222-34. PubMed ID: 21328541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A second-generation recombinant BCG strain combines protection against murine tuberculosis with an enhanced safety profile in immunocompromised hosts.
    Valencia-Hernandez AM; Zhao G; Miranda-Hernandez S; Segura-Cerda CA; Pedroza-Roldan C; Seifert J; Aceves-Sanchez MJ; Burciaga-Flores M; Gutierrez-Ortega A; Del Pozo-Ramos L; Flores-Valdez MA; Kupz A
    Vaccine; 2024 Oct; 42(24):126291. PubMed ID: 39241355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin.
    Begum D; Umemura M; Yahagi A; Okamoto Y; Hamada S; Oshiro K; Matsuzaki G
    Immunology; 2009 Dec; 128(4):556-63. PubMed ID: 19930045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination Strategies Against Mycobacterium tuberculosis: BCG and Beyond.
    Ferluga J; Yasmin H; Bhakta S; Kishore U
    Adv Exp Med Biol; 2021; 1313():217-240. PubMed ID: 34661897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
    Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
    Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant BCG ΔureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses.
    Desel C; Dorhoi A; Bandermann S; Grode L; Eisele B; Kaufmann SH
    J Infect Dis; 2011 Nov; 204(10):1573-84. PubMed ID: 21933877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.